GRP
LYEL icon

Global Retirement Partners’s Lyell Immunopharma LYEL Stock Holding History

Global Retirement Partners’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-155
Closed -$4.27K – 3733
2024
Q3 		$4.27K Buy
+155
New +$4.55K ﹤0.01% 2633

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
VP
venBio Partners San Francisco, California $281M AUM 261.03% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Global Retirement Partners's LYEL Position: Q4 2024 in Review

Global Retirement Partners sold out of Lyell Immunopharma (LYEL) in Q4 2024, closing a stake of 155 shares — an estimated $4.27K sold.

Global Retirement Partners first reported a position in LYEL in Q3 2024 and held it in 1 quarter. The position peaked at $4.27K in Q3 2024. 105 funds tracked by Wall St. Rank hold LYEL as of Q4 2024.

  • Global Retirement Partners reported no remaining Lyell Immunopharma position as of Q4 2024 after selling out during the quarter.
  • Global Retirement Partners sold 155 Lyell Immunopharma shares in Q4 2024, an estimated $4.27K.
  • Global Retirement Partners first reported a position in Lyell Immunopharma in Q3 2024 and held it in 1 quarter.
  • Global Retirement Partners's Lyell Immunopharma position peaked at $4.27K in Q3 2024.
  • 105 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.